Trials / Unknown
UnknownNCT01188330
Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival
Randomized Study Comparing the Interest of a Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival of Elderly Patients With Acute Myeloid Leukaemia. MLSP/IPC 2009-003
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
Acute myeloid leukaemia (AML) is a disease of the elderly, with a median age at diagnosis of 65. A poor outcome in this population has been well established, with very short overall survival (OS) and disease free survival (DFS).There are numerous bad prognostic factors related to the disease itself or to the patient's medical condition. This study will evaluate the impact of a Comprehensive Geriatric assessment (CGA) performed at diagnosis with planned interventions according to disabilities and monthly follow-up by a nurse practitioner during 6 months on functional status of older cancer patients treated for Acute myeloid leukaemia. Functional status will be assessed with the Lawson Instrumental Activities of Daily Living (IADL) scale at diagnosis and 6 months after randomisation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | WITH Comprehensive Geriatric assessment | Each month after randomization, a nurse practitioner will systematically review the intervention plan. In case of hospitalisation, the nurse will go and meet the patient and his care giver to check each point of the intervention plan. If an action has not been done, a new proposal will be made to the patient. If the patient is at home or in institution, the nurse practitioner will call the patient and /or his care giver for the same purpose |
| BEHAVIORAL | Conventional | no Comprehensive Geriatric assessment |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2016-09-01
- First posted
- 2010-08-25
- Last updated
- 2013-10-31
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01188330. Inclusion in this directory is not an endorsement.